Corindus Vascular Robotics
CVRS
CVRS was delisted on the 28th of October, 2019.
35 hedge funds and large institutions have $222M invested in Corindus Vascular Robotics in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 8 closing their positions.
2,720% more capital inflows, than outflows
Capital inflows: $82.8M | Capital outflows: $2.94M
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
21.55% more ownership
Funds ownership: 36.81% → 58.36% (+22%)
15% less funds holding
Funds holding: 41 → 35 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.76M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$804K |
| 3 |
GAM Holding
Zurich,
Switzerland
|
+$643K |
| 4 |
Clough Capital Partners
Boston,
Massachusetts
|
+$312K |
| 5 |
BlackRock Institutional Trust
San Francisco,
California
|
+$92.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.66M |
| 2 |
UBS O'Connor
Chicago,
Illinois
|
-$444K |
| 3 |
Millennium Management
New York
|
-$339K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$204K |
| 5 |
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$147K |
CVRS Hedge Fund Activity: Q4 2015 in Review
35 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Corindus Vascular Robotics (CVRS) for Q4 2015, worth a combined $222M — up 75% from $127M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CVRS and 2 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 17 added.
The largest buyer was Wellington Management Group, adding an estimated $2.76M. The largest seller was Goldman Sachs, cutting an estimated $1.66M.
- 35 institutional investors held Corindus Vascular Robotics (CVRS) as of Q4 2015, down from 41 in Q3 2015.
- Funds reported $222M of Corindus Vascular Robotics stock for Q4 2015, up 75% quarter-over-quarter.
- 2 funds opened new Corindus Vascular Robotics positions in Q4 2015 and 8 closed out, a net change of -6 holders.
- The largest Corindus Vascular Robotics buyer in Q4 2015 was Wellington Management Group, an estimated $2.76M added.
- The largest Corindus Vascular Robotics seller in Q4 2015 was Goldman Sachs, an estimated $1.66M sold.
Based on aggregated 13F filings for Q4 2015.